Adial Pharmaceuticals, Inc.
ADIL
$0.2454
$0.00642.68%
NASDAQ
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -52.92% | 32.66% | 1,547.45% | 169.91% | 117.29% |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -4.36% | -17.06% | -12.73% | 106.35% | 23.28% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -91.60% |
Total Current Assets | -50.73% | 26.89% | 394.81% | 86.79% | 80.00% |
|
|||||
Total Current Assets | -50.73% | 26.89% | 394.81% | 86.79% | 80.00% |
Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -15.79% | -15.38% | -14.63% | -14.29% | -99.17% |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | -48.37% | 6.49% | 134.10% | 30.96% | 71.32% |
|
|||||
Total Accounts Payable | 218.76% | 134.22% | 288.40% | 183.53% | -66.52% |
Total Accrued Expenses | 96.91% | 28.88% | 16.48% | 3.14% | -68.04% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
Total Other Current Liabilities | -- | -- | -- | -- | -- |
Total Current Liabilities | 135.38% | 49.43% | 56.95% | 45.50% | -68.70% |
|
|||||
Total Current Liabilities | 135.38% | 49.43% | 56.95% | 45.50% | -68.70% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 135.38% | 49.43% | 56.95% | 45.50% | -77.14% |
|
|||||
Common Stock & APIC | 6.09% | 18.09% | 23.97% | 19.18% | 19.66% |
Retained Earnings | -11.89% | -19.18% | -19.51% | -18.69% | -13.06% |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | -65.26% | -0.38% | 151.52% | 28.93% | 325.18% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -65.26% | -0.38% | 151.52% | 28.93% | 325.18% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -65.26% | -0.38% | 151.52% | 28.93% | 325.18% |
|